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Guided by amulti-level ‘‘deconstruction’’ of omental metastases, we developed a
tetra (four cell)-culture model of primary human mesothelial cells, fibroblasts, ad-
ipocytes, and high-grade serous ovarian cancer (HGSOC) cell lines. This multi-
cellular model replicated key elements of human metastases and allowed
malignant cell invasion into the artificial omental structure. Prompted by findings
in patient biopsies, we used the model to investigate the role of platelets in ma-
lignant cell invasion and extracellular matrix, ECM, production. RNA (sequencing
and quantitative polymerase-chain reaction), protein (proteomics and immuno-
histochemistry) and image analysis revealed that platelets stimulated malignant
cell invasion and production of ECM molecules associated with poor prognosis.
Moreover, we found that platelet activation of mesothelial cells was critical in
stimulatingmalignant cell invasion.Whilst platelets likely activate bothmalignant
cells and mesothelial cells, the tetra-culture model allowed us to dissect the role
of both cell types and model the early stages of HGSOC metastases.
INTRODUCTION
Various components of the tumor microenvironment (TME) can act as barriers to effective cancer treat-
ments through suppressive or protective cell phenotypes, the upregulation or activation of resistance path-
ways, or through the composition of the acellular microenvironment. In the latter, the tumor extracellular
matrix (ECM) has been identified as a major barrier to effective cancer treatment, including checkpoint im-
munotherapies (Mariathasan et al., 2018; Tauriello et al., 2018), cell therapies (Anderson et al., 2017), and
small molecule chemotherapies (Kalluri, 2016). Whilst every invasive tumor will have a disease-associated
ECM, the composition of the ECM is both prognostic (Pearce et al., 2018) and predictive (Chakravarthy
et al., 2018) of therapy response, suggesting some ECM compositions are more tumor promoting than
others. The ECM is also important in the establishment of the metastatic niche through the interaction be-
tween circulating tumor cells and the microenvironment of a distant site, which can determine the success
of colonization and establishment of a metastatic lesion. Combination therapies that target global depo-
sition of ECM, such as TGFb inhibitors (Mariathasan et al., 2018; Tauriello et al., 2018), or specific ECM com-
ponents, for example in situ degradation of hyaluronic acid, can improve therapy response in murine can-
cer models (Hingorani et al., 2018). However, the tumor ECM can also be tumor-inhibitory by containing the
malignancy and slowing disease progression (Cox and Erler, 2016). Therefore, deconvoluting ECM produc-
tion from tumor inhibiting vs tumor promoting may identify approaches to inhibit tumor metastasis and
improve tumor response to emerging and established cancer therapies.
The aim of our research is to use human multi-cellular models to study cancer-associated ECM. Our
approach was to first ‘deconstruct’ the human cancer tissue that we wished to study, the commonly
occurring omental metastases of high-grade serous ovarian cancer (HGSOC) (Pearce et al., 2018). This
multi-level analysis at the biomechanical, cellular and molecular level provided us with a template and
validation for ‘reconstruction’ of the tissue in vitro. Using this template we developed a tetra-culture
model comprising human primary omental adipocytes, fibroblasts, mesothelial cells and early passage
HGSOCiScience 24, 102676, June 25, 2021 ª 2021
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Figure 1. Tri- and tetra-cultures are viable and resemble the structure of human omental metastasis
(A) Schematic figure shows the tri- and tetra-culture setup.
(B and C) (B) Tri-culture viability was recorded for 21 days using live/dead staining assay and confocal imaging (upper panels) and perilipin metabolic
adipocyte staining for immunohistochemistry (IHC) (lower panels) (scale bar 200 mm). The IF and IHC positivity for at least 3-5 gels for each time point was
then quantified and plotted. Data are represented as mean G SD (C).
(D) H&E and IHC staining using calretinin for the mesothelial cells and FAP for fibroblasts reveal that the structures of the tri-culture and the human tissue are
comparable (scale bar 100 mm).
(E) IF staining of the surface of the tri-culture model shows a uniform deposition of mesothelial cells (scale bar 100 mm).
(F) Representative image of the surface of tetra-culture gels stained for PAX8 and FAP that show that AOCS1 and fibroblasts form colonies on the surface of
the tetra-culture which are mimicking human omental metastatic structures as shown in Figure S1 (scale bar 100 mm).
(G) IF staining for PAX8 reveals that G164 cells adhere to the surface of the tetra-culture forming aggregates similar to those seen in humanmetastatic tissues
(scale bar 100 mm).
(H) Hierarchical cluster analysis of tetra- and penta-culture illustrates that both cluster more closely with historic HGSOC RNASeq (Pearce et al., 2018) tissue
than normal or adjacent omental tissues.
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sue invasion and the production of a tumor supportive ECM.
High platelet levels in blood are correlated with a significant poor prognosis in several cancer types,
including ovarian cancer (Stone et al., 2012). We wished to see if our multi-cellular human in vitro model
could add further mechanistic information to previous in vivo findings on the role of platelets in driving dis-
ease progression, metastasis and tissue invasion that have been studied in murinemodels (Cho et al., 2017;
Haemmerle et al., 2016, 2017; Hu et al., 2017; Labelle et al., 2011, 2014).
We found that platelets stimulate malignant cell invasion, ECM remodeling and production of ECM mol-
ecules associated with poor prognosis in the tetra-cultures. We then investigated the cell types involved in
these actions of platelets. Previous experiments in mouse cancer models found that platelet activation of
malignant cells leads to the generation of an EMT phenotype which drives tissue invasion during the early
stages of metastasis (Labelle et al., 2011). The human tetra-culture model allowed us to dissect the role of
individual cell types in a way that would not be possible in mouse cancer models. We found that platelet
activation stimulated an EMT phenotype inmalignant cells, but this was sufficient to stimulate their invasion
into the artificial omental contruct. Instead we found that platelet activation of mesothelial cells was essen-
tial for malignant cell invasion within our model. Whilst platelets likely activate both malignant cells and
mesothelial cells in disease, the tetra-culture model presented here has allowed us to dissect the role of
both cell types and we propose that it is activation of the mesothelial cells that is most important in driving
early stages of omental metastasis of HGSOC.RESULTS
Design and establishment of a multi-cellular model of HGSOC metastasis
In our previous work we deconstructed a metastatic site of high-grade serous ovarian cancer (HGSOC)
(Pearce et al., 2018), finding that omental tissue with low or no disease present was primarily constructed
of mature adipocytes with a surface layer of fibroblasts and mesothelial cells. Using a proteomic approach,
we also determined that the major component of the ECM (Naba et al., 2017) was collagen 1, which we
found made up over 50% of the tissue, and in some cases over 90% of the tissue. Therefore, to establish
a low or no disease human omental tissue model, freshly isolated primary omental adipocytes were set
within a 3D substrate of high-density collagen 1 to make an adipocyte-collagen gel monoculture. Next, pri-
mary omental fibroblasts were added to the surface of the adipocyte-collagen gel, followed by primary
omental mesothelial cells to generate amulticellular tri-culture that replicates some elements of the normal
omentum. An overview of the process is shown in Figure 1A.We then assessed the viability of the adipocyte
cultures over a period of 21 days using a fluorescent live/dead cell stain and determined that there was a
20%–30% reduction in adipocyte viability over 21 days (Figures 1B and 1C left panel). This was also
confirmed using perilipin A as a marker of adipocyte metabolic activity (Figure 1C right panel). From these
data, we established that the tri-culture models were viable and suitable for up to 21 days of co-culture.
Visual comparison with human omental tissue free from malignant disease (Figure 1D) showed that the
tri-culture recapitulated the normal tissue morphology in the arrangement of adipocytes (Figure 1D left
panels), the localization of calretinin staining for mesothelium (Figure 1D middle panels and Figure 1E),
and the localization of FAP + fibroblasts (Figure 1D right panels).iScience 24, 102676, June 25, 2021 3
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Figure 2. Platelets signaling is associated with MI and poor prognosis
(A) Heatmap of differentially expressed genes in matrix index high vs matrix index low samples (adjusted p value < 0.05, NMIhigh = 21, NMIlow = 72).
Samples (columns) have been ordered by increasing matrix index value. Genes (rows) have been clustered based on a pearson’s correlation matrix as
distance and the complete clustering method.
(B) Differential expression analysis was performed on the high versus low matrix index samples. Barplot illustrates top up and down-regulated genes (adj. p
value < 0.05).
(C) GSEA normalized enrichment scores (NES) for significantly upregulated signaling pathways between high and low matrix index in human tissue (FDR <0.05).
(D) Enrichment plots from the GSEA analysis showing a strong correlation between the MI signature and platelets and TGF-beta signaling pathways.
(E) Flow cytometry analysis of CD62P⁺ activated platelets in fresh blood, washing with physiologic solution and ascites fluid from patient diagnosed with
stage 3 and 4 HGSOC (n = 3) (**p < 0.01 one way ANOVA). Data are represented as mean G SD.
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AOCS1 (Milagre et al., 2015) (Figure 1F) or G164 (Tamura et al., 2020) (Figure 1G) as a single cell suspension,
creating an omental metastasis tetra-culture model. We found that both AOCS1 and G164 malignant cells
attached to the surface of the cultures forming colonies (Figure 1G), similar to what we observed in patient
tissues of early metastatic lesions (Figure S1A), where they could be clearly defined from other cells present
in the model using nuclear PAX8 as a marker.
Finally, we extracted RNA from the cultures and used RNAseq to investigate the transcriptomic profiles of tri-
and tetra-cultures and their similarities to human omental tissue with high or low/nometastasis. We found that
tri-culture of adipocytes, fibroblasts andmesothelial cells clusteredwith human omental tissue samples with no
or low disease whilst the tetra-culture with HGSOC malignant cells clustered with heavily diseased human
omentum samples (Figure 1H). Taken together, these data show that a viable and relevantmulti-cellular model
of early omentalmetastasismodel can be prepared in semi-high throughputmanner that partially self-arranges
at the cellular level. Next, we tested findings fromour previousHGSOC ‘deconstruction’ study using themodel.
Platelets and TGFb signaling are associated with the tumor ECM and poor prognosis
In our previous work we identified an ECM expression signature, MI, that associates with poor prognosis and
immunosuppressive cell phenotypes across 13 different human cancer types, including HGSOC (Pearce et al.,
2018). Using the ICGC HGSOC transcriptional database, we investigated the differentially expressed genes
between patient samples that had high vs low MI scores (Table S1, Figures 2A and 2B). We observed major
changes in ECM pathways (Figure 2C top panel) such as those involved in collagen formation or ECM regu-
lation. Using KEGG pathway analysis for biological processes, we also found strong associations between
the MI and platelet activation (Figure 2C bottom panel and 2D) confirming data published that associated
platelets with tumor progression in ovarian cancer (Stone et al., 2012). In concordance with this, we analyzed
the platelet content of fresh blood and ascites and confirmed that platelets are present predominantly in an
activated statewithin the ascites fluid frompatients diagnosedwith Stage 3/4 HGSOC (Figure 2E). Since plate-
lets have been correlated with a number of different processes including extravasation, establishment of the
metastatic niche, stimulation of an EMT phenotype and anoikis inhibition (Cho et al., 2017; Haemmerle et al.,
2016, 2017; Hu et al., 2017; Labelle et al., 2011, 2014; Laubli and Borsig, 2010), we decided to use the tetra-cul-
ture model to test whether platelets could stimulate ECM deposition and malignant cell invasion.
Platelet addition associates with ECM remodeling to a poor prognosis tumor matrisome
To test whether platelets were stimulating production of the disease-associated matrisome found previ-
ously (Pearce et al., 2018) and in Figure 2, we added human platelets to the tetra-culture to make a
‘‘penta’’-culture. After 10 days of culture, we compared the transcriptional changes in the tetra- and the
penta-culture using bulk RNAseq and compared the results to patient HGSOC omental metastases. The
transcriptomic profiles (Tables S2 and S3, and Figures S2A–S2D) showed that the tetra- and penta-cultures
clustered together and also clustered more closely with diseased HGSOC tissue than more normal or adja-
cent-to-tumor omental tissues (See penta-culture in Figure 1H). We then compared tetra-culture and
penta-culture transcriptomic profiles using reactome pathway analysis (Table S4 and Figure S2E), which
showed ECM organization pathways as the most highly enriched when platelets are present (Figure 3A
shows the pathways involved in ECM organization; 15 of a possible 18 pathways significant). Other signif-
icantly enriched pathways in the penta-cultures containing platelets were immune system (cytokine pro-
duction, most likely triggered through platelet action), post-translational modifications, hemostasis (indic-
ative of the presence of platelets including platelet degranulation, and response to elevated platelet
cytosolic Ca2+), smooth muscle contraction (that is associated with stromal cell activation in response to
tumor invasion), and circadian clock (Figure 3A).iScience 24, 102676, June 25, 2021 5
Figure 3. Platelet addition to the tetra-culture model stimulates ECM production and alters ECM composition
RNAseq was performed on tetra- and penta-cultures (n = 3 in each group).
(A) Significantly enriched Reactome pathways (p < 0.05) in penta-cultures compared to tetra-cultures include ECM organization, immune system and
hemostasis.
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Figure 3. Continued
(B) Analysis of matrisome compartment identified a significant increase in expression of glycoproteins and collagens, * = p < 0.05.
(C) Top differentially expressed matrisome genes and all genes between penta- and tetra-cultures include COL11a1, TNC, and TGFBI (p < 0.05).
(D) Boxplot showing median and interquartile range of MI in tetra- and penta-cultures (n = 3 in each group).
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and penta-cultures to look at the composition of the matrisome between these two conditions. We observed a
significant expansion in the glycoprotein and collagen compartments of the matrisome in the penta-cultures
(Figure 3B), which we had previously observed in our comparison between low and high diseased human
HGSOC tissue (Pearce et al., 2018). We also assessed the top genes differently expressed between penta-
and tetra-cultures (Figure 3C), where we identified several ECM molecules previously associated with poor
prognosis in cancer (COL11A1, TNC, TGFb1). Other top differentiated genes that resulted from the presence
of platelets included cancer-associated inflammatory cytokines CXCL5 and CCL5 which are associated with
invasiveness,metastasis (Romero-Morenoet al., 2019; Singh et al., 2018) andplatelet guided formation of amet-
astatic niche (Labelle et al., 2014). Since the addition of platelets within the model stimulated predominately an
ECM remodeling signature, we wondered whether platelets were also altering expression of the genes identi-
fied in our previously reported prognostic MI signature (Pearce et al., 2018). Comparing tetra-with penta-cul-
tures, we saw an enrichment of the MI in penta-cultures (Figure 3D). Overall, these transcriptional data indicate
that platelets are stimulating the production of a tumor ECM which has previously been associated with poor
prognosis in HGSOC, with the formation of a metastatic niche, and with malignant cell invasion within tissues.
Platelets stimulate ECM protein production within the 3D model
To further explore whether platelets were stimulating the production of a poor prognosis ECM, we as-
sessed two of the ECM molecules identified in our previous study on human HGSOC cancer tissue (Pearce
et al., 2018) that associated with poor prognosis, namely versican (VCAN), and fibronectin (FN1), within
tetra- and penta-cultures (Figure 4A). Using quantitative confocal microscopy, we found that penta-culture
models had significantly more VCAN and FN1 deposition within the culture compared to the tetra-cultures,
and that this expression was predominantly located where malignant cells were attaching or invading into
the model. VCAN and FN1 appeared to be deposited around both malignant cells and stromal cells (likely
fibroblasts and/or the mesothelial cells) present in the model (Figures 4B and 4C). We also observed a
higher number of EpCAM positive malignant cells in the platelet-treated cultures (Figure 4D) which was
confirmed by flow cytometry analysis on the whole cell population isolated from tetra- and penta-cultures
(Figure 4E). In addition to an increase in tumor cell numbers in the penta-culture, we had noted that ma-
lignant cells tended to form a disorganized corkscrew-like structure on the surface of the model that sug-
gested that the invasion of malignant cells into the tissue model was occurringmore readily in the presence
of platelets (Video S1). Moreover, the transcriptomic analysis showed in Figure 3 had also identified genes
associated with a more invasive phenotype in the penta-cultures.
Further analysis of five MI proteins upregulated in diseased HGSOC, FN1, VCAN, cartilage oligomeric ma-
trix protein, cathepsin B (CTSB), and collagen 11 (COL11A1), revealed an increased expression of all these
ECM proteins in the penta-cultures when compared to the tetra-cultures (Figure 4F), which was in keeping
with our analysis of the surface of the models (Figures 4A–4E).
Platelets stimulate malignant cell invasion
As described above (Figure 4F and Video S1), it seemed that platelets may be stimulating invasion of tumor
cells within the model. To test this further we stained cross sections of tetra- and penta-cultures with an
HGSOC-specific nuclear marker, PAX8, and counted the number of PAX8 positive cells that had invaded
into the interior of the model (Figure 4G, left and middle panels). There were significantly more PAX8 pos-
itive cells in penta-cultures compared to tetra-cultures (Figure 4G, right panel). Taken together these data
indicate that platelets stimulate ECM deposition, tumor cell proliferation, and malignant cell invasion
within this human multi-cellular model.
Platelets stimulate ECM and EMT gene processes in mesothelial cells and malignant cells
We then asked which cell type(s) within the model were facilitating the matrix deposition and tissue inva-
sion phenotype seen in penta-cultures. Using human HGSOC cell lines we observed that the binding be-
tween platelets and malignant cells stimulate an EMT phenoyte (Figure 5A) and that platelets bind to the
surface of malignant cells generating cell-platelet aggregates (Figure S3A), as previously shown in a murineiScience 24, 102676, June 25, 2021 7
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Figure 4. Platelet addition to the tetra-culture model increases ECM deposition and cancer cell invasion
(A) Schematic shows the model setup. First, fibroblast cells were plated on top of the adipocyte gel, followed by mesothelial. After 24 hr, HGSOC cells were
added on top to form the tetra-culture model. Fresh isolated platelets were then plated on the tetra-culture model to make the penta-culture model. After
7 days, tetra- and penta-culture were analyzed with confocal imaging and FACS.
(B and C) (B) IF staining of EpCAM positive G164 cells and FN1 and VCAN in tetra- and penta-cultures (scale bar 100 mm). The increased deposition of FN1
and VCAN in the penta-culture was then quantified in at least 2 gels per condition (n = 3) and plotted (C).
(D and E) (D) Quantification of EpCAM deposition demonstrates the presence of a higher number of malignant cells in the penta-culture which is confirmed
by flow cytometry analysis on EpCAM positive cells (n = 3) (E).
(F) IHC analysis of FN1, CTSB, COL11A1, VCAN, and COMP confirms an increase in ECM deposition in the penta-culture compared to the tetra- and tri-
cultures (representative images, n = 3) (scale bar 200 mm).
(G) H&E and PAX8 staining of the gels (left panel) shows a greater invasion in the presence of platelets (penta-culture) (scale bar 50-500 mm). PAX8 positive
nuclei that were further than 50 mm from the perimeter were counted in tetra- and penta-culture gels respectively (n = 3). Alla data are expressed as meanG
SD (*p < 0.05 and **p < 0.01; unpaired t test for 3C and 3D and paired t test for 3E).
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are able to alter the chemokine/cytokine profile of our HGSOC malignant cells (Figure S3B and Tables S5
and S6). To further support the finding of increased ECM deposition in the penta-culture model (Figure 4),
we analyzed the transcriptomic profile of HGSOC cell lines co-cultured with platelets and we found that
platelets stimulate a strong ECM gene profile in malignant cells (Table S6 and Figures S3C–S3G).
Next, we explored whether platelets may be activating invasion and ECM processes through other cells in
themodel. Using image stream analysis, we compared platelet binding and activation in cultures of primary
omental mesothelial cells and primary omental fibroblasts (Figures S4A–S4C) and we found that platelets
were activated and bound to both cell types. However, we noted that more platelets were bound and acti-
vated on mesothelial cells compared to fibroblasts (Figures S4A–S4C). These data indicate that platelets
bind mesothelial cells and become activated in a comparable manner to malignant cells (Figure S3A)
but less so with primarily human omental fibroblasts. We then tested whether platelets altered the ECM
and EMT gene profile in HGSOC cell lines, primary mesothelial cells, and primary fibroblasts. Platelets
increased the expression of EMT and ECM genes in both mesothelial and malignant cells, and the fold
change in expression was significantly higher for some genes in mesothelial cells compared to malignant
cells (Figures 5A and 5B). This was also confirmed in malignant cells at protein level for two of the EMT
genes analyzed (Figure S4D). In contrast, these same EMT and ECM gene profiles did not appear to be
altered by platelets in fibroblasts (Figures 5A and 5B). From these data, we concluded that platelets stim-
ulated ECM and EMT gene expression in mesothelial cells and malignant cells but not fibroblasts.Platelet activation of mesothelial cells disrupts the mesothelial barrier permitting malignant
cell invasion into the tissue
We next asked whether platelet activation of malignant cells or mesothelial cells wasmost important to ma-
lignant cell invasion using the multi-cellular model. Since mesothelial cells were also activated by platelets,
we decided to investigate whether they were involved in the invasion of malignant cells. Malignant cells
were cultured on the adipocyte gels (the base for building the tetra- and penta-cultures described in the
previous figures) with or without mesothelial cells and with or without platelets (Figure 5C, left panels,
and Figure 5D). We found that malignant cells alone, malignant cells plus platelets, or malignant cells
plus mesothelial cells were unable to invade into the tissue model. However, when platelets were added
to the co-cultures of malignant andmesothelial cells significantmalignant cell invasion occurred (Figure 5C,
right panels, and Figure 5D). We next tested whether platelet activation of mesothelial cells alone was
enough to support malignant cell invasion. Mesothelial cells were plated on the surface of an adipocyte
gel and then activated with platelets prior the addition of malignant cells (Figure 5E). Platelet activation
of mesothelial cells was enough to facilitate malignant cell invasion into the tissue, indicating that direct
platelet activation of malignant cells was not essential for tissue invasion, if the mesothelial barrier was
already activated by platelets. Since we found that the TGFb pathway was associated with the expression
of our ECM signature in HGSOC tissue samples, we wanted to look if the inhibition of this pathway could
somehow alter the platelet-driven phenotype we observed in our penta-culture model. To do so, we added
a TGFb inhibitor to the adipocyte gels cultured with mesothelial and malignant cells with or without plate-
lets addition (Figure 6A), and we observed a complete inhibition of malignant cell invasion within the
model. Whilst we have not investigated the cellular source of TGFB in this model, it is likely, based on other
studies and from our own analysis of the cell lines used here (data not shown), that the primary source of
TGFb is the malignant cells. Taken together, these data demonstrate that platelet activation of mesothelialiScience 24, 102676, June 25, 2021 9
Figure 5. Mesothelial cells are the most affected by platelet activation
(A and B) Primary mesothelial cells were co-cultured with 100 platelets/cell for 72 hr before RT-quantitative polymerase-
chain reaction analysis of changes in (A) EMT gene expression and (B) Matrix Index gene expression. Y axis shows the
relative fold change in gene expression with platelets vs no platelets.
(C–E) (C) Schematic figures and PAX8 staining images showing the increased malignant cell invasion upon addition of
mesothelial cells and platelets to the model. PAX8 positive nuclei that were further than 50 mm from the perimeter were
counted in the different models (n = 3) (scale bar 200 mm) (D) or with/without removing platelets from the culture (n = 3) (E).
Data are presented as mean G SEM. Significance was determined using an unpaired t test or a one-way ANOVA with
Tukey’s post hoc test where * = p < 0.05, ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001.
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target the phenotype in mesothelial cells that platelets stimulate to inhibit malignant cell invasion.DISCUSSION
Here, we present a multi-cellular model of early HGSOC metastasis to the omentum that is constructed
from primary human cells, relevant early passage HGSOC cell lines and platelets to co-culture up to 510 iScience 24, 102676, June 25, 2021
Figure 6. A TGF-inhibitor can revert the invasion phenotype promoted by platelets
(A) Mesothelial and G164 cells were plated on top of the adipocyte gels. SB431542, a TGFb inhibitor, or fresh media was
added to the model prior platelets isolation and addition. After 7 days of incubation, gels were fixed and embedded.
PAX8 positive nuclei that were further than 50 mm from the perimeter were counted in at least 3 gels for each condition
(n = 2) (data are expressed as mean G SD; one-way ANOVA with Tukey’s post hoc test ** = p < 0.01, scale bar 250 mm).
(B) The schematic figure shows the importance of the mesothelial activation by platelets to promote invasion in our
model.
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human tissue of interest and then use this as a template and validation for a ‘‘reconstruction’’. Histopath-
ological comparison of models with the relevant human tissue revealed comparable arrangements of cells
indicating the model is partially self-assembling, with the preparation of the 3D primary adipocyte mono-
culture being the only step requiring physical arrangement of cells by setting adipocytes at high concen-
tration within a collagen 1 matrix. Moreover, there were significant transcriptional similarities in many dis-
ease-associated pathways between these models and the diseased tissue.
As recently discussed (Rodrigues et al., 2020), there is a need for 3D multi-cellular models that can recapit-
ulate the complex interactions between malignant cells and their microenvironment. We believe that the
approach here, which uses primary adipocytes as the substrate and is based on a deep understanding of
the tissue to be modeled, is a useful addition to the field especially in terms of studying cell-cell and cell-
ECM interactions. Within the model adipocytes appear to stimulate tumor growth (Figure S5), which occurs
in vivo in several cancer types that metastasize to fatty tissues including melanoma (Zhang et al., 2018),
breast (Wang et al., 2017), and pancreatic cancer (Lengyel et al., 2018). Adipocytes may also be important
in stimulating an invasive EMT phenotype in malignant cells (Lengyel et al., 2018). In addition, for the pur-
pose of investigating tissue remodeling, the loose connective tissue structure of adipose tissue provides a
clear baseline for visual analysis of tissue remodeling that is occurring during tumor cell invasion that, as
shown here, appear as aligned fibers (Figure 4B lower images).
These multi-cellular models were made in a 96-well format and can be used in a semi-high throughput
manner, limited only by fresh tissue availability, over approx. 20 days of culture. These models are partic-
ularly useful for studying the early stages of metastasis and the tissue remodeling that accompanies this.
Whilst we have focused on ovarian omental metastasis, the same approach would lend itself well to other
metastatic or primary cancer sites where the normal tissue contains a significant amount of loose connec-
tive tissue with a high adipocyte content, such as breast, pancreatic, and liver tissues. As demonstratediScience 24, 102676, June 25, 2021 11
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allowing the dissection of cell-types that are involved in the process. In this context, the model revealed
platelet contribution to activation of mesothelial cells in metastasis, which had not been identified from
previous in vivo studies, where deconvolution of cell roles could not be explored so easily. We did not
explore fibroblasts in helping tumor cells to invade within our models because they did not appear to be
activated by platelets. However, there is a body of literature that indicates fibroblasts are involved in tu-
mor invasion, for example, fibroblasts lay down ECM tracks that traveling cancer cells follow (for a review
that covers this concept please see (Kalluri, 2016)). Additionally, we also explored in this model how
platelets stimulate the production of a tumor ECM that has been previously associated with poor prog-
nosis and failure to immunotherapy response. Recently several papers have highlighted the importance
of tumor ECM in the response rate to immunotherapy (Chakravarthy et al., 2018; Mariathasan et al., 2018;
Tauriello et al., 2018), and there are several clinical trials ongoing which aim to target tumor ECM. There-
fore the tissue model presented here may be particularly useful for exploring the role of ECM in tumor
immunity and immunotherapy response given the strong matrix signature seen (Figures 3, S2, and S3)
and the easily observable and quantifiable changes in ECM remodeling that the model affords (Figures
4A and 4B).
In this work, we used this platform to explore the role of platelets in HGSOC omental metastasis based on
the association between platelet processes and our ECM gene signature (Figure 2) found through the anal-
ysis of human cancer tissue (Pearce et al., 2018). Platelets have a long association with disease progression
and metastasis. Classical studies indicate a role for them in shielding circulating tumor cells from immuno-
surveillance and potentially aiding tumor cells in hijacking the process of leukocyte rolling during metas-
tasis (Laubli and Borsig, 2010). However, more recent studies have found that platelets may also be impor-
tant in establishment of two separate stages in disease progression, namely the establishment of the early
metastatic niche (Haemmerle et al., 2017; Labelle et al., 2011, 2014) and secondly the vascularization and
proliferation of established tumors (Haemmerle et al., 2016; Hu et al., 2017). Adding to this, the work pre-
sented here provides a fourth role for platelets in cancer dissemination and progression through activation
of the tissue mesothelial surface and the deposition of a tumor promoting and therapy inhibiting extracel-
lular matrix. This tumor-associated extracellular matrix appears to be driven through TGFb and Hedgehog
signaling, as we found using a multi-cellular tri-culture HGSOC model, built using the same principles
described here (Delaine-Smith et al., 2021).
Evidence from epidemiological studies of long-term regular aspirin use, an inhibitor of platelet activa-
tion, is associated with reduced cancer risk including ovarian cancer, further implicating a role for plate-
lets in this disease (Cuzick, 2017). Therefore, taken together, cancer therapies that target platelet activa-
tion or block cell-platelet binding may inhibit metastasis, tumor growth, and the development and
maintenance of TMEs that are therapy resistant. Targeting platelets in combination with emerging
and established cancer therapies may be a promising avenue of cancer therapy, and we suggest that
the model presented here is an ideal test platform for these studies and others where tissue invasion
and ECM remodeling is involved.Limitations of the study
Other cell types have also been implicated in the establishment of the metatstatic niche, in particular gran-
ulocytes and macrophages, which are not included within the model presented here.STAR+METHODS
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Hernando-Momblona, X., et al. (2018). TGFb
drives immune evasion in genetically
reconstituted colon cancer metastasis. Nature
554, 538–543.
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KEY RESOURCES TABLEREAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Monoclonal Mouse Anti Alpha Smooth Muscle Actin Sigma Cat #A2547; RRID:AB_476701
Polyclonal Rabbit Anti Versican Sigma Cat# HPA004726, RRID:AB_1080561
Polyclonal Rabbit Anti COL11A1 Sigma Cat# HPA052246; RRID:N/A
Polyclonal Rabbit Anti FN1 Sigma Cat# F3648, RRID:AB_476976
PE anti-human CD42b Biolegend Cat# 303905, RRID:AB_314385
Monoclonal Rabbit anti-fibroblast activation protein, alpha Abcam Cat# ab207178, RRID:AB_2864720
Monoclonal Rat anti COMP Abcam Cat# ab11056, RRID:AB_297708
Monoclonal Mouse anti CTSB Abcam Cat# ab58802, RRID:AB_940824
Polyclonal Rabbit anti PAX8 Novus Cat# NBP1-32440, RRID:AB_2283498
Human anti EpCAM Alexa Flour 488 ThermoFisher Cat# 53-8326-41, RRID:AB_11220074
APC anti-human CD62P (P-Selectin) Biolegend Cat# 304910, RRID:AB_314482
Human Fibroblast Activation Protein alpha PE-conjugated
Antibody (FAP-PE) (Clone # 427819)
R&D systems Cat# FAB3715P; RRID: N/A
Human alpha-Smooth Muscle Actin APC-conjugated
Antibody (aSMA-APC) (Clone #1A4)
R&D systems Cat# IC1420A, RRID:AB_10890600
Human anti EpCAM Brilliant Violet 650 Biolegend Cat# 324225, RRID:AB_2562734
Biotinylated goat anti-rabbit IgG antibody 1.5mg Vector Labs Cat# BA-1000, RRID:AB_2313606
Biotinylated goat anti-rabbit IgG antibody 1.5mg Vector Labs Cat# BA-9200, RRID:AB_2336171
Polyclonal Rabbit anti CALB2 Sigma Cat# HPA007305, RRID:AB_1078386
Chemicals, Peptides, and Recombinant Proteins
Trypsin-EDTA solution 10X Sigma T4174
DMEM/F12 with Glutamax Thermo Fisher Scientific 31331093
FBS Fisher Scientific 10500-064
Collagenase type I powder Thermo Fisher Scientific 17100017
SB431542 hydrate Sigma S4317
EDTA Thermo Fisher Scientific AM9262
L-Ascorbic acid 2-phosphate sesquimagnesium salt hydrate Sigma A8960
Collagen I from rat tail Thermo Fisher Scientific A1048301
DMEM low glucose 10x Sigma D2429
Agarose, low gelling temperature Sigma A0701
Goat serum 100ml Life Technologies 16210064
Fixable Viability Dye eFluor 450 eBioscience 65-0863-18
Agilent RNA 6000 Pico Reagents Agilent 5067-1514
Medium-199 Thermo Fisher Scientific 22350029
Fluorescein diacetate Sigma F7378-5G
Ethidium Homodimer I Solution Sigma E1903
Insulin-Transferrin-Selenium-Sodium Pyruvate (ITS-A) (100X) Thermo Fisher Scientific 51300044
Zytomed Antibody diluent Bioscience LifeSciences ZUC025-500
Bovine Serum Albumin Sigma A4503
Hydrogen Peroxide 30% (w/v) (100 Volumes), Extra Pure
SLR, Fisher Chemical
Fisher Scientific 10687022
(Continued on next page)
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REAGENT or RESOURCE SOURCE IDENTIFIER
Vectastain Elite ABC HRP Kit Vector Laboratories PK-6100
SIGMAFAST DAB Tablets Sigma D4293
Hematoxylin Solution, Gill No. 1 Sigma GHS116
Formalin solution neutral buffered 10 Sigma HT501128-4L
DPX Mountant for histology Sigma 06522
Triton X-100 Sigma T8787
DAPI Biotium 40043
Sodium Chloride Sigma 71383
Potassium Chloride Sigma P9541
Sodium bicarbonate Sigma S5761
HEPES Sigma H0887
Magnesium chloride Sigma M8266
Sodium phosphate dibasic heptahydrate Sigma S2429
Prostaglandin E1 Sigma P5515
Apyrase Sigma A6535
Critical Commercial Assays
RNeasy Mini Kit (50) Qiagen 74104
High-Capacity cDNA Reverse Transcription Kit
(200 reactions)
Thermo Fisher Scientific 4368814
iTaq Universal Probes Supermix (10 x 1ml) Biorad 1725132
Deposited Data
RNASeq platelets on G164-MCMs GEO GSE155547
RNASeq platelets on G164-spheroids GEO GSE155546
Experimental Models: Cell Lines
Human AOCS1 Kindly gifted by Prof D Bowtell’s lab (Tamura et al., 2020)
Human G164 isolated in our lab (Tamura et al., 2020)
Oligonucleotides
See Table S7 N/A
Software and Algorithms
FlowJo 9.4.6 Treestar Inc. https://www.flowjo.com/
GraphPad Prism 8.3.0 GraphPad https://www.graphpad.com/scientific-
software/prism/
R 3.1.3 NA http://www.R-project.org
HTSeq https://htseq.readthedocs.io/
en/release_0.11.1/
Anders et al., 2014
EdgeR Bioconductor Robinson and Oshlack, 2010
Limma Bioconductor Ritchie et al., 2015
GSEA https://www.genepattern.org/ Subramanian et al., 2005
Biorender https://biorender.com/ Some graphical abstract components
were created with Biorender.com
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Lead contact
Further information and requests for resources and data should be directed to the lead contact, Oliver
Pearce (o.pearce@qmul.ac.uk), Barts Cancer Institute, Queen Mary University of London Charterhouse
Square EC1M 6BQ, London, UK.16 iScience 24, 102676, June 25, 2021
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ArticleMaterials availability
This study did not generate new unique reagents.
Data and code availability
The accession number for the RNASeq data reported in this paper is Gene Expression Omnibus (GEO):
GSE155547 (platelets on G164-MCMs) and GSE155546 (platelets on G164-spheroids).
EXPERIMENTAL MODELS AND SUBJECT DETAILS
Isolation and of mesothelial cells, fibroblasts, and adipocytes from human omentum
Samples were collected by Barts Gynae Tissue Bank (HTA license number 12199. REC no: 10/H0304/14)
from women undergoing omentectomy and omental biopsy after giving written informed consent (age
range 40-87 yo). Use of the tissue for medical research was approved by a UK national review board.
Approximately 10 cm3 of omentum was submerged in 0.25% trypsin (Sigma-Aldrich) and incubated at
37C for 20 min. Trypsin was neutralized with growth medium (DMEM:F12 (Gibco) with 10% heat-inacti-
vated FBS (Hyclone) and penicillin-streptomycin (Sigma-Aldrich)). The cell suspension was centrifuged at
200 x g for 5 min and the pelleted mesothelial cells resuspended in growth medium and cultured at
37C, 5% CO2. After isolation, cells were grown to confluency. The cells were defined as mesothelial cells
based on the cobblestone morphology and flow cytometry for calretinin positivity and EpCAM negativity.
We estimate purity to be >95%. The tissue was then minced with scalpels and suspended in 0.5 mg/ml
collagenase type I (Gibco) in growth medium and placed in a shaking incubator at 50 rpm, 37C for
75 min. Digested tissue was passed once through a 250 mm tissue strainer (Thermo-Fisher) and the adipo-
cyte layer collected and washed by centrifuging twice at 200 x g in DMEMwith 5% FBS. The fibroblast pellet
from the first adipocyte wash was resuspended in growth medium and cultured at 37C, 5% CO2 . After
three days, any unattached cells were washed away with 1X PBS and the morphology of the attached cells
was checked and then referred to as fibroblasts. Multiple fibroblast donors have been used for each exper-
iment. Cells were defined as fibroblasts based on their spindle like morphology and by flow cytometry (cal-
retinin- EpCAM-) and by IF for SMA+FAP+. We estimate purity to be >95 %.
Ascite and peritoneal wash fluids collection and processing
Uncoagulated ascite and peritoneal washes fluids were collected by Barts Gynae Tissue Bank from women
undergoing ovarian cancer surgery. Ascite fluids were spun down at 1000 x g for 10 min to sediment plate-
lets. Platelets from peritoneal washes were isolated following the isolation of platelets from peripheral
blood samples described below. After the latest wash in MTH buffer, platelets from peripheral blood
and peritoneal washes were resuspended in FACS buffer prior the FACS staining. Isolated platelets
were counted and stained for CD42b to identify the platelet population and for CD62P to identify the acti-
vated platelets.
Isolation of platelets from peripheral blood samples
Blood was collected from female healthy donors under the permissions granted in the Barts Gynae Tissue
Bank HTA license (number 12199. REC no: 10/H0304/14) and centrifuged at 180 x g for 15min with no brake.
The supernatant was removed and prostaglandin E1 and apyrase were added to a final concentration of
1mM and 100 U/ml respectively. The platelet suspension was centrifuged at 100 x g for 4 min and the su-
pernatant centrifuged at 1000 x g for 10 min and resuspended in 5 ml MTH buffer (134 mM NaCl, 2.9 mM
KCl, 0.34 mM Na2HPO4, 12 mM NaHCO3, 20 mM HEPES, 1 mM MgCl2, 0.1% glucose, 0.35% BSA, pH 7.4)
before addition of PGE1 and apyrase as previously. The platelet pellet was washed once more in MTH
buffer (with PGE1 and apyrase) and resuspended in growth medium for co-culture experiments. After isola-
tion, platelet purity was checked by viewing using a cytometer which revealed no cell contamination and
flow cytometry using size, granularity, and platelet marker CD42. Purity was calculated as >99 %.
METHOD DETAILS
Casting adipocytes into collagen gels
Purified adipocytes were combined with the following reagents to give 1 mg/ml collagen adipocyte gels:
1ml of adipocyte suspension, 1 ml of 3 mg/ml rat-tail collagen I (Gibco), 100 ml of 10x DMEM low-glucose
(Sigma), 48 ml of 1M NaOH and 852 ml H2O. The adipocyte-collagen mixture is prepared on ice, quickly
transferred in 100 ml aliquots in a 96 well dish and incubated at 37oC, 5% CO2 for 30 min. Gels were theniScience 24, 102676, June 25, 2021 17
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within 7 days from the isolation. Adipocytes were characterized by morphological features of size and
shape. Once set in a collagen gel they were stained for perilipin-1 expressed by mature adipocytes. Based
on these two analysis no other cell contamination was detectable.
Tri-, tetra- and penta- culture models set up
Adipocyte gels were anchored to the bottom of a 96 well dish by incubating them on top of 20 ml of 1 mg/ml
rat-tail collagen I solution (per 100 ml of 3 mg/ml collagen: 30 ml DMEM low-glucose 10x, 4.8 ml of 1MNaOH,
165 ml H2O) for 10 min. Gels were then seeded with 40,000 primary human omental fibroblasts per gel and
incubated for 2 hr. The medium was then replaced with 200 ml of mesothelial cell medium (Medium 199
(Gibco) with insulin-transferrin-selenium (Gibco), 10% heat-inactivated FBS (Hyclone) and penicillin-strep-
tomycin (Sigma-Aldric)) containing 200,000 human primary mesothelial cells and incubated for 24 hr. G164
or AOCS1 ovarian cancer cells (Tamura et al., 2020) were then seeded at 40,000 cells per gel and incubated
for 24 hr before loosening and transferring the gels to a 24 well dish in growth medium. To make up the
penta-culture model, a ratio of 1:100 cancer cells:isolated platelets was added to the culture. After
24 hrs the media was replaced in all wells and SB431542 (TGFbeta inhibitor) and/or 4 million platelets/
gel added. The medium was replaced every 3-4 days until endpoint. AOCS1 (PMID: 25670170) and G164
cell lines were established fromHGSOComental metastasis tumors and subjected to STR sequencing anal-
ysis. AOCS1 cells were maintained in RPMI1640 with 10% FBS and 1% L-Glutamine and 1% penicillin-strep-
tomycin. G164 cells were maintained in DMEM:F12 plus Glutamax supplemented with 4% human serum
(Sigma Aldrich) and 1% penicillin-streptomycin.
Flow cytometry staining
Co-culture gels were digested in 1 mg/ml collagenase type I (Thermo-Fisher) in serum-free DMEM for 1 hr
at 110 rpm, 37C. Gels were then disaggregated and 0.5% trypsin-EDTA (Sigma-Aldrich) was added before
incubation in a water bath at 37C for 30 min. DMEM with 10% FBS was then added 1:1 to the cell suspen-
sion and centrifuged at 200 x g for 5 min. The pellet was resuspended in 250 ml of PBS and the cells counted
using a hemocytometer. Cells were washed in PBS and resuspended in 100 ml of FACS buffer (1X PBS +
2 mM EDTA and 2% FBS) containing 2 mg/ml of primary antibody (see antibody table) for 30 min. After
two washes in FACS buffer cells were fixed with a 1:1 mixture of neutral buffered formalin (Sigma-Aldrich)
and FACS buffer for 10 minutes on ice. Cells were stored in the dark at 4C before analysis by flow cytom-
eter. A minimum of 10,000 events were acquired on a BD LSRFortessa flow cytometer (BD Biosciences) us-
ing BD FACSDiva software (BD Biosciences) and analyzed using FloJo v10.6.1 software.
Live/dead assay
Gels were immersed in PBS containing 20 mg of fluorescein diacetate (Sigma-Aldrich) and 4 mM ethidium
homodimer (Sigma-Aldrich) for 10 min at 37C, after which they were placed on a glass slide. Gels were
imaged using a Zeiss LSM610 confocal microscope.
Immunohistochemistry
Formalin-fixed paraffin-embedded sections (4 mm) of omentum samples or co-cultures gels were heated for
1 hr at 60C and then submerged twice in xylene for 5 min. Immunohistochemistry was performed using a
Vectastain ABC Kit (Elite), as per the manufacturer’s instructions. Slides were rehydrated and heated-anti-
gen retrieval was performed using citric acid-based antigen unmasking solution (Vector Laboratories) and
heated in a 2100 antigen-retriever (Aptum Biologics). Endogenous peroxidase activity was blocked using
3%H2O2 in PBS and sections were then blocked with 5% BSA. The primary antibody was added in antibody
diluent (Zytomed) and covered at room temperature for 1 hr. Slides were incubated with a biotinylated sec-
ondary antibody (Vector) for 30 minutes. Subsequent steps were carried out according to the protocol
included with the Vectastain Elite ABC HRP kit, after which the slides were incubated with DAB solution
made using Sigmafast DAB tablets (Sigma-Aldrich). Finally, slides were counterstained in 50% Gill’s hema-
toxylin I, washed with water and dehydrated. After leaving to dry, coverslips were affixed using a drop of
DPX mountant (Sigma-Aldrich).
Quantification of cancer cell invasion
Adipocyte co-culture gels were fixed in 10% neutral buffered formalin then cast in 2% agarose gels, verti-
cally cross-sectioned and re-cast into 2% agarose before dehydration and paraffin embedding. Sections18 iScience 24, 102676, June 25, 2021
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ing a NanoZoomer S210 (Hamamatsu). For each gel section the number of PAX8 positive nuclei in the inte-
rior of the gel that were further than 50 mm from the perimeter was counted.
2D platelet co-culture
Cells were plated into a 6-well dish at 200,000 cells/well in growth medium. After 24 hr incubation, platelets
from a healthy donor were isolated and washed as described above and 100 platelets/seeded cells were
added to one well, media only was added to the remaining wells. Total RNA was collected after a 72 hr
incubation.
RNA isolation and real-time quantitative PCR
Total RNA was prepared from cell cultures using the RNeasy Mini Kit and the RNase free DNase set
(Qiagen). After washing cells or the tetra- and penta-cultures gels in PBS and addition of 350 ml of RLT
buffer, RNA was isolated according to the manufacturer’s instructions. The RNA was quantified using
the NanoDrop 2000c (Thermo-Fisher Scientific). The reverse-transcription reaction was carried out using
the T100 Thermal Cycler (Bio-Rad) and the High-Capacity cDNA Reverse Transcription Kit (Applied Bio-
systems) according to themanufacturer’s instructions. The PCR reaction was carried out using (Applied Bio-
systems) and FAM-MGB labeled Taqman gene expression assay probes. The reaction mixture for each
replicate contained 5 ml of cDNA at 1 ng/ml, 10 ml of Supermix, 1 ml of probe, 4 ml of RNase-free water,
and was run on a StepOnePlus Real-Time PCR System (Applied Biosystems). VIC labeled 18s RNA was
used as a housekeeping gene. The delta-delta Ct calculation has been used to quantify the gene expres-
sion. Results are shown as Log2 (fold change) of the Rq value.
ICGC analysis based on matrix index
The ICGC_OV read counts across 93 primary tumors were extracted from the exp_seq.OV-AU.tsv.gz file in
the ICGC data repository Release 20 (http://dcc.icgc.org). Overall survival (OS) was extracted from the do-
nor.OV-AU.tsv.gz file. Matrix index was calculated for each sample survival analysis was performed as
described in (Pearce et al., 2018). Differential expression of the 72 matrix index high versus 21 matrix index
low samples was undertaken using R package limma (Ritchie et al., 2015). GSEA analysis was run using
ranked t-statistic of all genes for MSigDB canonical pathways (Subramanian et al., 2005).
RNA-seq and analysis
RNA-seq was performed by the Wellcome Trust Centre for Human Genetics (Oxford, UK) to approximately
30x mean depth for the G164 spheroids or approximately 60x for the MCM cultures. The sequencing was
carried out on the Illumina HiSeq4000 strand-specific, generating 150bp paired-end reads, strand-specific.
RNA-Seq reads were mapped to the human genome (hg19, Genome Reference Consortium GRCh37) in
strand-specific mode as part of theWellcome Trust Centre pipeline. Number of reads aligned to the exonic
region of each gene were counted using htseq-count based on the Ensembl annotation (Anders et al.,
2014). Only genes that achieved at least one read count per million reads (cpm) in at least twenty-five
percent of the samples were kept. Conditional quantile normalization was performed counting for gene
length and GC content and a log2 transformed RPKM expressionmatrix was generated. Differential expres-
sion analysis was performed using R packages EdgeR and limma (Robinson andOshlack, 2010). GSEA anal-
ysis was run using ranked t-statistics of all genes from the comparison Penta-culture vs Tetra-culture for
MSigDB Canonical pathways. Significantly DE genes (FDR < 0.05) from the comparison G164 Spheroids
plus Platelets vs Spheroids were ranked by log2 fold change used for GSEA for MSigDB Canonical path-
ways. RNA-Seq data have been deposited in Gene Expression Omnibus (GEO) under the accession
numbers GSE155547 (platelets on G164-MCMs) and GSE155546 (platelets on G164-spheroids).
Immunofluorescence of 3D cultures
Gels were fixed in 10% neutral buffered formalin. Subsequently, Triton X-100 (0.5% in PBS) was added to the
gels and incubated for 10 min. Gels were washed and incubated in blocking solution (PBS with 5% BSA),
which was replaced with the primary antibody in antibody diluent (Zytomed) and incubated overnight at
4C. Gels were then washed before a fluorescent secondary antibody was added in antibody
diluent and protected from light while shaking for 1 hr. Finally, gels were incubated with PBS containing
0.4 mg/ml DAPI, washed in PBS for 5 min, and imaged using a Zeiss LSM510 confocal microscope using
a 10x or 20x air objective. Tetra- and penta- culture images were acquired using a field of view equal toiScience 24, 102676, June 25, 2021 19
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Article238.1 x 238.1mm containing 1024x1024 pixels. All imaging conditions were kept constant for all the
experiments.Image stream analysis from 2D co-culture
500,000 cells and/or platelets were scraped in PBS and pelleted by centrifugation at 1000 x g for 5 minutes
and resuspended in FACS buffer (2mM EDTA, 2% FBS in PBS) on ice. Normal protocol for FACS staining
was followed as described previously. A minimum of 1,000 events was acquired on an Amnis ImageStream
X Mk II (Luminex) using IDEAS v6.2 for both acquisition and analysis.QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analyses were performed in GraphPad Prism or the programming language R (version 3.1.3). To
compare two groups, unpaired t-test was used while for pairwise comparisons a two-way paired t-test was
used. To compare more than two groups, one-way ANOVA with Tukey’s HSD test were used if not other-
wise indicates. The differential expression analysis was performed in Edge R using limma (PMID:25605792)
while gene set enrichment analysis (GSEA) was completed using the GSEA software (Mootha et al., 2003) to
identify the canonical pathways gene sets from the Molecular Signatures Database (MSigDB-C2-CP v6.2).
Data were considered statistically significant from p < 0.05.20 iScience 24, 102676, June 25, 2021
